Losartan (Cozaar) will be promoted to prevent stroke

May 2003

Losartan (Cozaar) will be promoted to prevent stroke.

The FDA just approved this new indication for patients with hypertension and left ventricular hypertrophy (LVH).

LVH is a risk factor for stroke. Hypertensive patients with LVH have about twice the risk of stroke as those without it.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote